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Abstract 
The human T-cell lymphotropic virus type 1
(HTLV-1),  endemic  in  defined  geographical
areas around the world, is recognized as the
etiologic  agent  of  adult  T-cell  leukemia/lym-
phoma (ATL), or HTLV-1. ATL is a rare adult
onset T-cell malignancy that is characterized
by the presence of ATL flower cells with T-cell
markers, HTLV-1 antibodies in the serum, and
monoclonal integration of HTLV-1 provirus in
affected cells. Ocular manifestations associat-
ed  with  HTLV-1  virus  infection  have  been
reported and include HTLV-1 uveitis and kera-
toconjunctivitis  sicca,  but  reports  of  ocular
involvement in ATL are exceedingly rare.  This
article describes the ocular manifestations and
pathology of ATL. We also report for the first
time a case of a 34-year-old male with systemic
ATL and prominent atypical lymphoid cell infil-
tration in the choroid.  To our knowledge, this
is the first report defining prominent choroidal
involvement as a distinct ocular manifestation
of ATL.  ATL may masquerade as a variety of
other  conditions,  and  molecular  techniques
involving  microdissection  and  PCR  have
proven  to  be  critical  diagnostic  tools.  Inter  -
national collaboration will be needed to better
understand the presentation and diagnosis of
this rare malignancy.
Introduction
The human T-cell lymphotropic virus type 1
(HTLV-1) was first isolated in 1980 from two T-
cell lymphoblastoid cell lines and the blood of a
patient with cutaneous T-cell lymphoma.
1 This
was the first retrovirus to be causally linked to
human disease, and it is now recognized as
the  etiologic  agent  of  HTLV-1  associated
myelopathy/tropical spastic paraparesis, HTLV-
1  associated  uveitis,  various  additional
autoimmune and inflammatory diseases, and
HTLV-1 associated adult T-cell leukemia/lym-
phoma (ATL).
2 HTLV-1 infection is endemic in
southwestern  Japan,  the  Caribbean,  and
Central Africa. HTLV-1 carriers are also preva-
lent in South America, Papua New Guinea, and
the Solomon Islands.  It has been estimated
that there are 10-20 million HTLV-1 infected
individuals worldwide.
3
HTLV-1 infection occurs primarily through
the transmission of infected cells with inte-
grated HTLV-1 provirus via breast feeding, con-
taminated  blood,  and  sexual  contact.  In  the
host, the virus initially spreads from cell to cell
through viral synapses and later proliferates by
clonal expansion of the infected T-cells.
4 The
HTLV-1  genome  includes  gag,  pol,  and  env,
three genes that are common to all retrovirus-
es,  and  a  unique  pX  region  that  contains  4
open reading frames (ORFs). Several regulato-
ry genes are encoded in the pX region, among
which tax, rex, and HTLV-1 basic leucine zipper
factor (HBZ) have been shown to play critical
roles in HTLV-1 mediated leukemogenesis. ATL
has an extended latency period between infec-
tion and the onset of ATL symptoms, and less
than 5% of HTLV-1 infected individuals develop
ATL.
5,6 This  suggests  that  multiple  complex
molecular events are required in ATL patho-
genesis.
7
Case Report
Choroidal  manifestations  of  ATL  are
extremely  rare.  Cases  involving  choroidal
thickening and the infiltration of a few scat-
tered atypical lymphoid cells have been report-
ed.
8,9 Recently,  a  34-year-old  Jamaican  male
with a history of systemic ATL was seen at the
National  Cancer  Institute  at  the  National
Institutes of Health (NIH). A previous comput-
ed tomography scan had shown large masses
in the abdomen, chest, and neck, and echocar-
diography revealed a 20ﾥ20 mm mass in the
interventricular septum. The patient was ini-
tially  treated  with  CHOP  chemotherapy
[cyclophosphamide,  hydroxydaunorubicin
(doxorubicin),  oncovin  (vincristine),  and
prednisone/prednisolone], followed by CMED
(cyclophosphamide,  methotrexate,  etoposide
and dexamethasone), with minimal response.
He developed fever, chills, nausea, and vomit-
ing,  which  progressed  to  respiratory  failure
over 10 days, before being admitted to the NIH
for  decitabine  and  vorinostat  treatment.  He
was  intubated  and  placed  on  levophed  for
hypotension. Blood cultures revealed Entero  -
coccus faecalis and Candida tropicalis sepsis.
Despite aggressive antimicrobial therapy, the
patient expired, and an autopsy was performed
in accordance with established protocols. 
The autopsy revealed large ATL masses in
the neck, mediastinum, mesentery, retroperi-
toneum,  and  myocardium.  Autopsied  eye
examination disclosed aggregates of moderate
small to medium sized atypical lymphocytes in
the posterior choroid of both eyes (Figure 1A
and  B),  more  prominently  temporally.
Occasional  small  choroidal  vessels  were
packed with atypical CD3
+ (Figure 1C), CD25
+,
and CD20
– lymphoid cells. 
Atypical lymphoid cells were microdissected
from the choroid. PCR showed T-cell receptor
(TCR)-γgene rearrangement and the presence
of the HTLV-1 gene pol in the microdissected
lymphoma cells (Figure 1D). Interestingly, the
HTLV-1 gene tax was undetectable. The results
confirmed monoclonal expansion and the pres-
ence of HTLV-1 provirus. For the first time, we
report prominent atypical lymphoid cell infil-
tration in the choroid with unremarkable con-
junctiva, cornea and retina in an ATL patient.
Substantial  choroidal  involvement  can  be
regarded as a new ocular manifestation of ATL.
Adult T-cell leukemia/lymphoma
ATL is an adult onset T-cell malignancy that
is  diagnostically  defined  by  morphologically
atypical  lymphoid  cells  with  basophilic  cyto-
plasm, multilobed nuclei, and T-cell markers;
HTLV-1 antibodies in the serum; and molecular
Rare Tumors 2010; volume 2:e63
Correspondence:  Chi-Chao  Chan,  10  Center
Drive, Bldg. 10, Rm. 10N103, NIH/NEI, Bethesda,
MD 20895-1857, USA. E-mail: chanc@nei.nih.gov
Key  words:  adult  T-cell  leukemia/lymphoma,
human T-lymphotrophic virus type 1, pathology,
eye.
Contributions: MML manuscript writing; EF, man-
uscript writing, critical review and revision; XC
contributed pathological case, critical review and
revision; DS generated molecular data; CCC man-
uscript guideline, critical review and revision.
Conflict of interest: the authors report no con-
flicts of interest.
Received for publication: 27 September 2010.
Revision received: 10 November 2010.
Accepted for publication: 10 November 2010.
This work is licensed under a Creative Commons
Attribution 3.0 License (by-nc 3.0).
©Copyright M.M. Liu et al., 2010
Licensee PAGEPress, Italy
Rare Tumors 2010; 2:e63
doi:10.4081/rt.2010.e63[page 180] [Rare Tumors 2010; 2:e63]
demonstration  of  monoclonal  integration  of
HTLV-1 provirus in affected cells.
10 The inci-
dence  of  ATL  is  estimated  to  be  61/100,000
HTLV-1 carriers, and the crude lifetime risk for
developing ATL is 7.29% for males and 3.78%
for females.
11 ATL is classified into 4 subtypes:
acute,  lymphoma,  chronic,  and  smoldering.
12
In all but the lymphoma subtype, ATL flower
cells (Figure 2) are present in the peripheral
blood.  The  canonical  subtype  is  the  acute,
accounting  for  55-75%  of  all  ATL  cases.
2
Lymphadenopathy,  hepatosplenomegaly,  skin
lesions, osteolytic bone lesions, and hypercal-
cemia are common.
13 Systemic lymphadenopa-
thy  without  peripheral  blood  involvement
defines the lymphoma subtype. Patients with
chronic ATL have lymphocytosis, ≥5% atypical
T-lymphocytes, skin lesions, and no hypercal-
cemia  or  organomegaly.  Smoldering  ATL  is
defined by the presence of atypical T-lympho-
cytes without lymphocytosis or organ involve-
ment, though patients may present with skin
or pulmonary lesions. 
The  acute  and  lymphoma  subtypes  are
resistant to chemotherapy and are considered
to be aggressive forms of ATL with poor prog-
nosis.  The  chronic  and  smoldering  subtypes
are considered to be indolent, though they may
progress to an aggressive form within several
years.
14 The median survival times for acute,
lymphoma,  chronic,  and  smoldering  ATL  are
estimated to be 4-6 months, 9-10 months, 17-
24  months,  and  ≥34  months,  respectively.
15
ATL  primarily  affects  the  skin,  lungs,  lymph
nodes,  liver,  spleen,  central  nervous  system,
bones,  and  gastrointestinal  tract.
12 Affected
patients  are  also  immune  compromised  and
susceptible  to  opportunistic  infections.
Although the involvement of other organs is
rare, several cases of ocular involvement have
been reported. The ocular manifestations and
pathology of ATL are discussed below.
Ocular manifestations and pathology
The  first  case  of  orbital  involvement  was
reported by Lauer et al in 1988.
16 A 41-year-old
Jamaican male developed proptosis and a large
orbital  tumor  3  years  after  being  diagnosed
with  systemic  ATL.  Histological  analysis
showed  large  lymphoid  cell  infiltrates  and
necrosis. The ATL cells had large nuclei with
prominent  nucleoli,  scanty  cytoplasm,  many
polysomes,  and  a  few  swollen  mitochondria.
Bilateral orbital tumor, causing exophthalmos
and eyelid edema, has also been reported as
the first presenting manifestation of ATL in a
64-year-old Japanese male who did not have
any  other  systemic  symptoms.
17 Biopsy
revealed atypical lymphoid cells in the orbital
adipose tissues that were positive for the T-cell
markers CD3 and CD5. Nodular, mass, and ery-
thematous eyelid lesions and eyelid lymphoma
have also been reported.
8,18-21
Corneal  manifestations  of  ATL  include
peripheral ulcerative keratitis, immunoprotein
keratopathy (hypergammaglobulinemia), cen-
tral stromal opacities or deposits, and corneal
haze, thinning, scarring, edema, and neovascu-
larization (Figure 3).
8,18 Bilateral conjunctival
masses have also been reported in a 29-year-old
Jamaican male.
19 From a conjunctival biopsy,
infiltration of CD3 and CD4 positive atypical
lymphoid cells with scanty cytoplasm and mul-
tilobed nuclei was observed in the substantia
propria. Yellowish conjunctival nodular lesions
have  manifested  with  aqueous  tear-deficient
keratoconjunctivitis  sicca  and  conjunctival
injection.
18 Yellow-white lesions have also been
observed along the limbal conjunctiva and into
the cornea, and lesions near the corneal limbus
have shown calcification.
21 Biopsy of the con-
junctival lesion revealed leukemic T-cell infil-
tration in the subepithelial layer. 
Recurrent episcleritis and ocular hyperemia
are signs that have been reported to precede
the manifestation of systemic ATL.
22 Lens man-
ifestations include nuclear sclerosis
18 and dif-
fuse opacities.
21 Several groups have reported
vitreous  opacities  due  to  ATL  cell  infiltra-
tion.
9,20,23-25 ATL patients also present with ante-
rior uveitis. Iritis, cyclitis, aqueous cells and
flare, keratic precipitates, and synechiae are
common manifestations.
20,23,24 In a 33-year-old
Japanese female with a 10 year history of sys-
temic ATL, anterior uveitis was reported to be
the first ocular manifestation.
8 Aqueous cells,
fibrin  membrane,  hyphema,  hemorrhages,
anterior chamber opacity, and mass lesions on
the iris were observed. Optic nerve manifesta-
tions of ATL include optic disc edema and optic
nerve thickening, and direct infiltration of ATL
cells in the optic nerve has been reported as
well.
9,24,26
Kohno  et  al. reported  a  case  of  retinal
involvement  in  a  38-year-old  Japanese  male
with ATL.
9 In addition to cells in the anterior
chamber and vitreous opacities, the retina was
edematous,  detached,  atrophic,  and  necrotic
with total disorganization of the retinal struc-
ture. Multiple white lesions could be seen in
the peripheral retina, and the retinal vessels
showed white sheathing indicative of vasculi-
tis. Microscopic findings revealed atypical lym-
phoid  infiltration  around  the  retinal  veins,
near breaks in the inner limiting membrane,
in the subretinal space, and between the reti-
nal  pigment  epithelium  (RPE)  and  Bruch’s
membrane. The malignant cells were positive
for T-cell markers and had irregular pleomor-
phic  nuclei,  peripheral  chromatin  condensa-
tion, and prominent lysosomes. A case of reti-
nal  infiltration  with  atrophic  lesions  in  the
retinal  vessels  and  the  choriocapillaris  has
demonstrated that ATL cells can enter the reti-
na  via  the  choroidal  circulation.
23 Retinal
sheathing,  venous  dilation  and  vasculitis,
edema, folds, lesions, and exudates with cotton
wool  spots  have  also  been  seen.
24,25,27
Case Report
Figure 1. Atypical lymphocytes in the poste-
rior choroid of both eyes. (A) Atypical lym-
phoid infiltrate in the choroid. The retina
and subretinal space are not involved. (B)
High power shows that the atypical lympho-
cytes  vary  in  size.  They  are  larger  than
mature lymphocytes. The clumps of these
cells  in  the  vessels  indicate  hematologic
spread of the tumor. (C) These tumor cells
are CD3 positive (shown by the dark color
in this stain). (D) The microdissected atypi-
cal lymphoid cells in the choroid are positive
for T-cell receptor (TCR)-ʳ￿ gene rearrange-
ment and the HTLV-1 pol gene. TCR-CDR3
gene rearrangement and the HTLV-1 genes
gag and tax were not detected. 
A
B
C
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Additionally,  the  retina  may  be  affected  by
opportunistic infections such as cytomegalo  -
virus retinitis. Such a case has been reported,
and histological analysis showed cytomegalic
cell infiltration and widespread retinal necro-
sis and disorganization.
20
A case of retinal and subretinal infiltration
without  vitreous  involvement  has  also  been
reported  in  a  38-year-old  male  of  Caribbean
origin.
28 Funduscopic  examination  revealed
pale subretinal lesions and cotton-wool spots.
Histological analysis of the chorioretinal biop-
sy specimen showed RPE atrophy and areas of
RPE  proliferation.  Pleomorphic  lymphocytes
with  scanty  cytoplasm,  hyperchromatic  and
convoluted  nuclei,  prominent  nucleoli,  little
endoplasmic reticulum, and many lysosomes
were observed in the subretinal space and the
outer retina. ATL cell infiltration in all retinal
layers, particularly in the neuroretina, has also
been demonstrated in a 51-year old male with
acute  ATL.
24 Rarely,  ATL  may  manifest  as  a
necrotizing  granulomatous  retinal  vasculitis.
This was reported in a 40-year-old Jamaican
female who was referred to the National Eye
Institute  at  the  NIH.
29 Fundus  examination
showed vitreous cells with haze, posterior vit-
reous detachment, infiltrates near the retinal
vessels,  vascular  sheathing,  deep  retinal
lesions,  and  macular  edema.  Retinal  biopsy
revealed  necrotizing  granulomatous  retinal
vasculitis and a few areas of retinal neovascu-
larization.  Molecular analysis revealed TCRγ
gene rearrangement and the presence of the
HTLV-1 gene pol in the infiltrating cells, allow-
ing for a definitive diagnosis of ATL.
Conclusions
In addition to the current case, microdissec-
tion and PCR techniques have been success-
fully  used  to  diagnose  ATL  involving  ocular
manifestations in previously reported cases.
19,29
Analysis  for  multiple  integrations  of  HTLV-1
proviral DNA using Southern blot may also be
useful, as it has been shown that multiple inte-
grations are correlated with more aggressive
clinical manifestations and the involvement of
nontraditional tissues, such as the retina and
the uvea.
24 Ocular manifestations of ATL are
uncommon  (Table  1)  and  have  also  been
broadly regarded as markers of poor progno-
sis.
19 Elevated levels of of soluble IL-2 receptor
alpha  (sIL-2Rʱ) may  suggest  direct  ocular
infiltration  of  ATL  cells,  as  T  leukemic  cells
constitutively  express  and  secrete  soluble
forms  of  this  protein  into  the  vitreous.
Consequently, vitreous levels of sIL-2Rʱ may
be an indicator of ocular infiltration and prog-
nosis as well.
25 Opportunistic infectious ocular
lesions, such as cytomegalovirus retinitis, are
also associated with poor prognosis. One study
observed that 4 out of the 5 patients who devel-
oped  such  lesions  died  within  several
months.
20 Early  detection  using  both  clinical
and molecular markers to diagnose ATL and
identify  signs  of  poor  prognosis  may  permit
earlier interventions. Because ATL is so rare,
international collaboration will be necessary to
elucidate and characterize the various factors
that  influence  ocular  manifestations  of  this
devastating tumor.
Case Report
Figure 2. ATL flower cell in the peripheral
blood.  Characteristic  ATL  cells  have  been
described as flower cells, with many nuclear
convolutions and lobules. They are medium
to large lymphoid cells with irregular nuclei
and basophilic cytoplasm.
Figure  3.  Corneal  manifestations  of  ATL.
Image shows keratitis with central stromal
opacities and neovascularization. 
Table 1. Ocular manifestations of HTLV-1 infection.
ATL Non-ATL
Orbit Proptosis, exophthalmos, tumor, ATL cell infiltration, necrosis
16,17
Eyelid Nodular mass, erythematous lymphomatous lesions
8,18-21
Cornea Peripheral ulcerative keratitis, immunoprotein keratopathy 
(hypergammaglobulinemia), central stromal opacities/deposits, 
haze, thinning, scarring, edema, neovascularization
18
Conjunctiva Conjunctival mass, nodular lesion, aqueous tear-deficient 
keratoconjunctivitis sicca, conjunctival injection, 
calcified lesion
18,19,21
Sclera Recurrent episcleritis, ocular hyperemia
22
Lens Nuclear sclerosis, diffuse opacities
18,21
Vitreous Opacity due to ATL cell infiltration
9,20,23-25 HTLV-1-associated 
uveitis (HAU): Vitritis, 
snowball opacities
HTLV-I-associated 
myelopathy/Tropical 
spastic paraparesis 
(HAM/TSP): 
vitreous opacity
20,30
Uvea Anterior uveitis, iritis, cyclitis, aqueous cells,  HAU: Iritis, cyclitis,
aqueous flare, keratic precipitates, synechiae,  aqueous cells,
fibrin membrane, hyphemia, hemorrhages, mass  aqueous flare,
lesions on iris, ATL cell infiltration of choroid
8,20,23,24 posterior synechiae,
keratic precipitates
HAM/TSP: 
anterior uveitis
20,30
Optic nerve Optic disc edema, optic nerve thickening,  Cotton wool spots
ATL cell infiltration
9,25,26 near optic disc
20
Retina Edema, detachment, atrophy, necrosis, lesions, vascular  HAU: cotton-wool
sheathing, vasculitis, ATL cell infiltration, CMV retinitis,  spots, exudates,
cotton-wool spots
9,20,23-25,27,29 hemorrhages,
vasculitis
HAM/TSP: 
cotton-wool spots
20,30
Subretina/RPE Lesions, cotton-wool spots, RPE atrophy, RPE proliferation
28
Systemic Lymphadenopathy, hepatosplenomegaly, lesions  HAM/TSP: upper motor
(skin, lungs, bone), hypercalcemia, ATL cells in peripheral neuron myelopathy,
blood, opportunistic infections
12-15 bladder dysfunction
20[page 182] [Rare Tumors 2010; 2:e63]
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